United States Pharma Excipients Market Report 2017

REPORT ID 655

Publish Date

01-Dec-17

Pages

100

Format

Electronic (PDF)

Full report description

In this report, the United States Pharma Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Pharma Excipients in these regions, from 2012 to 2022 (forecast).

United States Pharma Excipients market competition by top manufacturers/players, with Pharma Excipients sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Archer Daniels Midland (ADM)
    BASF
    DOW Chemical Company
    Evonik
    J.M. Huber Corporation
    ABITEC Corporation
    Cargill
    Eastman Chemical Company
    AkzoNobel

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Polymers
    Alcohols
    Minerals
    Sugar
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oral Solid Dosage Forms (OSDF)
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

United States Pharma Excipients Market Report 2017
1 Pharma Excipients Overview
    1.1 Product Overview and Scope of Pharma Excipients
    1.2 Classification of Pharma Excipients by Product Category
        1.2.1 United States Pharma Excipients Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Pharma Excipients Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Polymers
        1.2.4 Alcohols
        1.2.5 Minerals
        1.2.6 Sugar
        1.2.7 Others
    1.3 United States Pharma Excipients Market by Application/End Users
        1.3.1 United States Pharma Excipients Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Oral Solid Dosage Forms (OSDF)
        1.3.3 Others
    1.4 United States Pharma Excipients Market by Region
        1.4.1 United States Pharma Excipients Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Pharma Excipients Status and Prospect (2012-2022)
        1.4.3 Southwest Pharma Excipients Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Pharma Excipients Status and Prospect (2012-2022)
        1.4.5 New England Pharma Excipients Status and Prospect (2012-2022)
        1.4.6 The South Pharma Excipients Status and Prospect (2012-2022)
        1.4.7 The Midwest Pharma Excipients Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Pharma Excipients (2012-2022)
        1.5.1 United States Pharma Excipients Sales and Growth Rate (2012-2022)
        1.5.2 United States Pharma Excipients Revenue and Growth Rate (2012-2022)

2 United States Pharma Excipients Market Competition by Players/Suppliers
    2.1 United States Pharma Excipients Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Pharma Excipients Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Pharma Excipients Average Price by Players/Suppliers (2012-2017)
    2.4 United States Pharma Excipients Market Competitive Situation and Trends
        2.4.1 United States Pharma Excipients Market Concentration Rate
        2.4.2 United States Pharma Excipients Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Pharma Excipients Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pharma Excipients Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Pharma Excipients Sales and Market Share by Region (2012-2017)
    3.2 United States Pharma Excipients Revenue and Market Share by Region (2012-2017)
    3.3 United States Pharma Excipients Price by Region (2012-2017)

4 United States Pharma Excipients Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Pharma Excipients Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Pharma Excipients Revenue and Market Share by Type (2012-2017)
    4.3 United States Pharma Excipients Price by Type (2012-2017)
    4.4 United States Pharma Excipients Sales Growth Rate by Type (2012-2017)

5 United States Pharma Excipients Sales (Volume) by Application (2012-2017)
    5.1 United States Pharma Excipients Sales and Market Share by Application (2012-2017)
    5.2 United States Pharma Excipients Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Pharma Excipients Players/Suppliers Profiles and Sales Data
    6.1 Archer Daniels Midland (ADM)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pharma Excipients Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 BASF
        6.2.2 Pharma Excipients Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 BASF Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 DOW Chemical Company
        6.3.2 Pharma Excipients Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 DOW Chemical Company Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Evonik
        6.4.2 Pharma Excipients Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Evonik Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 J.M. Huber Corporation
        6.5.2 Pharma Excipients Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 J.M. Huber Corporation Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 ABITEC Corporation
        6.6.2 Pharma Excipients Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 ABITEC Corporation Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Cargill
        6.7.2 Pharma Excipients Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Cargill Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Eastman Chemical Company
        6.8.2 Pharma Excipients Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Eastman Chemical Company Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 AkzoNobel
        6.9.2 Pharma Excipients Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 AkzoNobel Pharma Excipients Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Pharma Excipients Manufacturing Cost Analysis
    7.1 Pharma Excipients Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pharma Excipients

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pharma Excipients Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pharma Excipients Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Pharma Excipients Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Pharma Excipients Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Pharma Excipients Sales Volume Forecast by Type (2017-2022)
    11.3 United States Pharma Excipients Sales Volume Forecast by Application (2017-2022)
    11.4 United States Pharma Excipients Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer